all you really have to compare it to is AGN at a 70 million market cap before GLP and phase 1 studies in 2021, NYR is a more effective treatment with no need of combining it with thrombotics and a single therapy and not a dual therapy which is already proven to work
Current market cap is 22 million with 5 million in cash and 3-4 million in rebates coming after July 1st. Got a significant rerate to go as it was at 40 cents last time without it being proven and this current results exceeded modelling so previous highs will be tested short term
- Forums
- ASX - By Stock
- NYR
- Nyrada Talks PreClinical Success with 180 Markets
Nyrada Talks PreClinical Success with 180 Markets, page-91
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.4¢ |
Change
0.001(1.89%) |
Mkt cap ! $9.839M |
Open | High | Low | Value | Volume |
5.3¢ | 5.6¢ | 5.3¢ | $5.863K | 105.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 31480 | 5.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 177449 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 31480 | 0.054 |
1 | 10000 | 0.053 |
2 | 300000 | 0.050 |
2 | 90000 | 0.049 |
2 | 220812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.057 | 177449 | 3 |
0.058 | 172400 | 1 |
0.060 | 10000 | 1 |
0.062 | 9000 | 1 |
0.063 | 132075 | 1 |
Last trade - 12.33pm 29/07/2024 (20 minute delay) ? |
Featured News
NYR (ASX) Chart |